Location History:
- Bern, CH (1999)
- Dornach, CH (2012 - 2021)
Company Filing History:
3 out of 3,923 
1 out of 126 
1 out of 284 
Years Active: 1999-2021
Title: The Innovative Contributions of Jonathan Hall
Introduction
Jonathan Hall is a notable inventor based in Dornach, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the synthesis of oligoribonucleotides and the treatment of neurological disorders. With a total of 5 patents to his name, Hall's work has had a profound impact on medical research and therapeutic applications.
Latest Patents
Among his latest patents, Hall has developed methods for the stereoselective synthesis of phosphorothioate oligoribonucleotides. This invention relates to chiral phosphoramidites represented by specific chemical formulas. Additionally, he has patented a method for treating neurological disorders through the administration of double-stranded RNA (dsRNA). This innovative approach involves intrathecal injection of an effective amount of dsRNA to inhibit the expression of target genes, providing a new avenue for therapeutic intervention.
Career Highlights
Throughout his career, Jonathan Hall has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Finance Corporation. His experience in these organizations has allowed him to contribute to groundbreaking research and development projects.
Collaborations
Hall has collaborated with esteemed colleagues such as Robert Haner and Gabriele Dorn. These partnerships have fostered a collaborative environment that has enhanced the quality and impact of his research.
Conclusion
Jonathan Hall's innovative work in biotechnology and his contributions to the field through his patents demonstrate his commitment to advancing medical science. His inventions hold promise for future therapeutic applications and highlight the importance of research in addressing complex health challenges.